Press releases

Approval should bring a new treatment option to the millions of women who suffer from uterine fibroids.

CABARNET clinical trial to evaluate the benefits of stenting in conjunction with embolic protection to treat carotid artery disease.

"We are very pleased with the enthusiasm with which the TAXUS system has been received, particularly the positive physician feedback," said Jim Tobin, President and Chief Executive Officer

Approval of paclitaxel-eluting coronary stent system marks a breakthrough event for the treatment of cardiovascular disease in the United States.

Kerkrade site will house Company's new distribution center serving European, Japanese and Inter-Continental markets.